ELITE PHARMACEUTICALS INC /NV/ (ELTP)
About ELITE PHARMACEUTICALS INC /NV/
ELITE PHARMS INC
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $84.0M
- Net income
- -$4.3M
- Total assets
- $96.4M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Elite Pharmaceuticals Inc /NV/ (ELTP) Stock Price
- Reported a net loss of $4.3M in FY2025.
- Trading 49% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review ELITE PHARMACEUTICALS INC /NV/.
Write a review
News about ELITE PHARMACEUTICALS INC /NV/
News & sentiment via Polygon.io
Elite Pharmaceuticals Inc /NV/: frequently asked questions
Is Elite Pharmaceuticals Inc /NV/ an American company?
Elite Pharmaceuticals Inc /NV/ is a US-based company headquartered in Northvale, New Jersey, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Elite Pharmaceuticals Inc /NV/ headquartered?
Elite Pharmaceuticals Inc /NV/ is headquartered in Northvale, New Jersey, United States.
Is Elite Pharmaceuticals Inc /NV/ publicly traded?
Yes — Elite Pharmaceuticals Inc /NV/ is a publicly traded company. Its stock trades under the ticker symbol ELTP on the OTC.
What does Elite Pharmaceuticals Inc /NV/ do?
Elite Pharmaceuticals Inc /NV/ is an American Pharmaceuticals company in the Health & Beauty sector.
